UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.  20549


FORM 8-K


CURRENT REPORT

Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934


Date of Report (Date of earliest event reported): September 30, 2016


Medical Imaging Corp.

(Exact name of registrant as specified in charter)


Nevada

333-1364363

98-0493698

(State or other jurisdiction

of incorporation)

(Commission

File Number)

(IRS Employer

Identification No.)


848 N. Rainbow Blvd. #2494

Las Vegas, Nevada

 

89107

(Address of principal executive offices)

 

(Zip Code)


Registrant’s telephone number, including area code (877) 331-3444


(Former name or former address, if changed since last report.)


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):


o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)


o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)


o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))


o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))








Item 5.07 Submission of Matters to a Vote of Security Holders


The 2016 Annual Meeting of Stockholders (the Annual Meeting”) of Medical Imaging Corp. (the “Company”) was held on September 30, 2016.


The Company’s stockholders voted on three proposals as follows: to elect Company directors for the ensuing year (Proposal 1); To approve, by non-binding vote, the Company’s executive compensation (Proposal 2) and to ratify the selection by the Company’s Board of Directors of Accell as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2016 (Proposal 3).


All nominees for election to the Board as Directors were elected to serve until the 2017 Annual Meeting of Stockholders and until their respective successors are elected and qualified, or until such director’s earlier death, resignation or removal. The Stockholders approved the non-binding vote for Proposal 2. The stockholders ratified Proposal 3. The number of votes cast for, against or withheld and the number of abstentions and broker non-votes with respect to each Proposal is set forth below.


Proposal 1

 

Shares For

 

Shares Withheld

 

Broker Non-Votes

 

 

 

 

 

 

 

Mitchel Geisler

 

15,612,447

 

12,000

 

0

Richard Jagodnik

 

15,612,447

 

12,000

 

0


 

 

Shares For

 

Shares Against

 

Shares Abstaining

 

Broker Non-Votes

 

 

 

 

 

 

 

 

 

Proposal 2

 

15,121,447

 

97,000

 

1,000

 

0


 

 

Shares For

 

Shares Against

 

Shares Abstaining

 

Broker Non-Votes

 

 

 

 

 

 

 

 

 

Proposal 3

 

16,247,621

 

137,153

 

0

 

0








SIGNATURES


Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.



 

Medical Imaging Corp.

 

 

 

Dated:  October 5, 2016

By:

/s/ Mitchell Geisler

 

 

Name:  Mitchell Geisler

 

 

Title:  Chief Executive Officer